Reports Q2 revenue $184.8M vs. $192.1M last year. Akumin delivered second quarter same-store volume performance on a consolidated basis as follows:+3.1% for MRI, +16.5% for PET/CT, +3.4% for Oncology Patient Starts.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AKU:
